Charles River Laboratories International (CRL) Total Non-Current Liabilities (2016 - 2025)
Charles River Laboratories International has reported Total Non-Current Liabilities over the past 17 years, most recently at $3.8 billion for Q4 2025.
- Quarterly results put Total Non-Current Liabilities at $3.8 billion for Q4 2025, down 1.02% from a year ago — trailing twelve months through Dec 2025 was $3.8 billion (down 1.02% YoY), and the annual figure for FY2025 was $3.8 billion, down 1.02%.
- Total Non-Current Liabilities for Q4 2025 was $3.8 billion at Charles River Laboratories International, down from $3.9 billion in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for CRL hit a ceiling of $4.6 billion in Q2 2022 and a floor of $3.4 billion in Q1 2021.
- Median Total Non-Current Liabilities over the past 5 years was $4.2 billion (2021), compared with a mean of $4.1 billion.
- Biggest five-year swings in Total Non-Current Liabilities: soared 33.34% in 2021 and later dropped 11.31% in 2024.
- Charles River Laboratories International's Total Non-Current Liabilities stood at $4.2 billion in 2021, then rose by 5.13% to $4.4 billion in 2022, then fell by 2.08% to $4.3 billion in 2023, then fell by 11.31% to $3.8 billion in 2024, then dropped by 1.02% to $3.8 billion in 2025.
- The last three reported values for Total Non-Current Liabilities were $3.8 billion (Q4 2025), $3.9 billion (Q3 2025), and $4.0 billion (Q2 2025) per Business Quant data.